Cervical Cancer: Clinical Feature, Trial and Management
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 58
Special Issue Editors
Interests: gynecologic
Interests: sugery; laparoscopy; hysteroscopy; ultrasound; gynecological malignancies; diagnosis
Special Issue Information
Dear Colleagues,
Cervical cancer (CC) is a major public health problem, ranking as the fourth most common cause of cancer incidence and mortality in women worldwide. There are geographical variations in cervical cancer that reflect differences particularly in the prevalence of human papillomavirus (HPV) infection. Squamous cell carcinomas account for approximately 80% of all cervical cancers and adenocarcinoma accounts for approximately 20%. The management and treatment of cervical cancer has been recently updated by ESGO/ESTRO/ESP in “Guidelines for the management of patients with cervical cancer - Update 2023”. However, there are still many gray areas that need to be resolved and there are still many novelties in the therapeutic field (both considering surgical and adjuvant radio/chemo- therapy) that need to be explored. As examples, we can cite the role of minimally invasive surgery (laparoscopy–robotic) for the treatment of locally advanced CC, the role of sentinel-node evaluation by ultra-staging, the safety and efficacy and adjuvant chemotherapy after definitive CTRT, new advances in immunotherapy, etc.
We are pleased to invite you to publish in our Special Issue that will cover all debated topics relating to the advances in CC diagnosis, management and treatment. For this Special Issue, original research articles, systematic review and meta-analysis are welcome.
Dr. Roberto Tozzi
Dr. Marco Noventa
Dr. Carlo Saccardi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cervical cancer
- diagnosis
- minimally invasive surgery
- laparoscopy
- locally advanced disease
- management
- treatment
- adjuvant chemotherapy
- immunotherapy
